Literature DB >> 34687713

Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition.

Carien Dekker1, Henri Mattes2, Michael Wright2, Andreas Boettcher2, Alexandra Hinniger2, Nicola Hughes2, Sandra Kapps-Fouthier2, Jörg Eder2, Paulus Erbel2, Nikolaus Stiefl2, Angela Mackay2, Christopher J Farady3.   

Abstract

The NLRP3 inflammasome assembles in response to a variety of pathogenic and sterile danger signals, resulting in the production of interleukin-1β and interleukin-18. NLRP3 is a key component of the innate immune system and has been implicated as a driver of a number of acute and chronic diseases. We report the 2.8 Å crystal structure of the NLRP3 NACHT domain in complex with an inhibitor. The structure defines a binding pocket formed by the four subdomains of the NACHT domain, and shows the inhibitor acts as an intramolecular glue, which locks the protein in an inactive conformation. It provides further molecular insight into our understanding of NLRP3 activation, helps to detail the residues involved in subdomain coordination within the NLRP3 NACHT domain, and gives molecular insights into how gain-of-function mutations de-stabilize the inactive conformation of NLRP3. Finally, it suggests stabilizing the auto-inhibited form of the NACHT domain is an effective way to inhibit NLRP3, and will aid the structure-based development of NLRP3 inhibitors for a range of inflammatory diseases.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MCC950; NLRP3 Inflammasome; crystal structure; gain-of-function; inhibition

Mesh:

Substances:

Year:  2021        PMID: 34687713     DOI: 10.1016/j.jmb.2021.167309

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors.

Authors:  David Harrison; Mark G Bock; John R Doedens; Christopher A Gabel; M Katharine Holloway; Arwel Lewis; Jane Scanlon; Andrew Sharpe; Iain D Simpson; Pamela Smolak; Grant Wishart; Alan P Watt
Journal:  ACS Med Chem Lett       Date:  2022-08-01       Impact factor: 4.632

2.  Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3.

Authors:  Inga V Hochheiser; Michael Pilsl; Gregor Hagelueken; Jonas Moecking; Michael Marleaux; Rebecca Brinkschulte; Eicke Latz; Christoph Engel; Matthias Geyer
Journal:  Nature       Date:  2022-02-03       Impact factor: 69.504

3.  Advances toward structure-based drug discovery for inflammasome targets.

Authors:  Li Wang; Michael A Crackower; Hao Wu
Journal:  J Exp Med       Date:  2021-11-16       Impact factor: 17.579

4.  Structure-Stability Relationship of NLRP3 Inflammasome-Inhibiting Sulfonylureas.

Authors:  Tim Keuler; Dominic Ferber; Michael Marleaux; Matthias Geyer; Michael Gütschow
Journal:  ACS Omega       Date:  2022-02-23

5.  Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation.

Authors:  Umeharu Ohto; Yukie Kamitsukasa; Hanako Ishida; Zhikuan Zhang; Karin Murakami; Chie Hirama; Sakiko Maekawa; Toshiyuki Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-07       Impact factor: 12.779

6.  Curcuma phaeocaulis Inhibits NLRP3 Inflammasome in Macrophages and Ameliorates Nanoparticle-Induced Airway Inflammation in Mice.

Authors:  Yeon-Ju Nam; Jiwon Choi; Jong Suk Lee; Changon Seo; Gyeongbeen Lee; Youngsu Lee; Jin Kyu Kim; Pansoo Kim; Jeong Ju Lim; Hyeon-Son Choi; Yongmun Choi
Journal:  Molecules       Date:  2022-03-24       Impact factor: 4.411

7.  The Inflammasome Activity of NLRP3 Is Independent of NEK7 in HEK293 Cells Co-Expressing ASC.

Authors:  Dominik Alexander Machtens; Ian Philipp Bresch; Jan Eberhage; Thomas Frank Reubold; Susanne Eschenburg
Journal:  Int J Mol Sci       Date:  2022-09-07       Impact factor: 6.208

Review 8.  A Selective Review and Virtual Screening Analysis of Natural Product Inhibitors of the NLRP3 Inflammasome.

Authors:  Sherihan El-Sayed; Sally Freeman; Richard A Bryce
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

Review 9.  Activation and regulation mechanisms of NOD-like receptors based on structural biology.

Authors:  Umeharu Ohto
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

10.  Acetylsalicylic Acid Suppresses Alcoholism-Induced Cognitive Impairment Associated with Atorvastatin Intake by Targeting Cerebral miRNA155 and NLRP3: In Vivo, and In Silico Study.

Authors:  Doaa I Mohamed; Dalia Alaa El-Din Aly El-Waseef; Enas S Nabih; Omnyah A El-Kharashi; Hanaa F Abd El-Kareem; Hebatallah H Abo Nahas; Basel A Abdel-Wahab; Yosra A Helmy; Samar Zuhair Alshawwa; Essa M Saied
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.